1) chrysotoxin
金黄毒
2) Jinhuangjiedu ointments
金黄解毒膏
1.
The contents of berberine hydrochloric in Jinhuangjiedu ointments in were determined by RP-HPLC.
目的建立金黄解毒膏的质量标准。
3) Includin garsenopyrite-pyrite
含金毒砂-黄铁矿
1.
Primary flotation preferred factors of a kind of Includin garsenopyrite-pyritewas studied.
对某含金毒砂-黄铁矿进行较详细浮选试验研究,通过正交试验获得浮选粗选的最佳工艺条件,当原矿含金5。
4) Staphylococcal enterotoxin
金黄色葡萄球菌肠毒素
1.
OBJECTIVE To clone the gene of staphylococcal enterotoxins E and obtain recombinant protein(rSEE),and study the activities of rSEE on mice lymphocyte and its lethal effects on tumor cells.
目的克隆金黄色葡萄球菌肠毒素E(SEE)基因,获得重组SEE蛋白(rSEE),并对rSEE进行生物活性分析。
2.
In section one , we evaluated the tumoricidal effect of staphylococcal enterotoxin C (SEC) which is one important superantigen(SAg).
实验的第一部分研究了金黄色葡萄球菌肠毒素C(SEC)的抗肿瘤作用。
3.
As potent activators of T lymphocytes, SEs (staphylococcal enterotoxins) have a potential to be used in tumor therapy.
金黄色葡萄球菌肠毒素作为强大的T细胞激活剂,对肿瘤的治疗有着潜在的应用价值。
5) Chryseobacterium meningosepticum
脑膜脓毒金黄杆菌
1.
Nosocomial Lung Infection by Chryseobacterium meningosepticum:Risk Factors and Drug-resistance;
医院获得性脑膜脓毒金黄杆菌所致肺部感染的危险因素及耐药性
2.
Antimicrobial Sensitivity of Chryseobacterium meningosepticum:Analysis of 36 Clinical Isolates;
36株脑膜脓毒金黄杆菌体外抗菌活性分析
3.
Nosocomial Pneumonia due to Chryseobacterium meningosepticum in Intensive Care Unit:Its Clinical Characteristics and Resistance;
重症监护病房内脑膜脓毒金黄杆菌医院感染肺炎临床及耐药分析
6) Staphylococcal enterotoxin A
金黄色葡萄球菌肠毒素A
1.
Two strategies, direct ligation after enzyme digestion and over-lap PCR technology, were adopted to construct a fusion gene which was composed of the antimelanoma single chain antibody gene and the staphylococcal enterotoxin A gene without N-terminal signal sequence.
采用酶切连接和重叠PCR连接两种方法将抗黑色素瘤单链抗体基因和去除N端信号肽的金黄色葡萄球菌肠毒素A基因进行融合 ,并将融合基因克隆于pET2 8 a表达载体上 ,转化大肠杆菌BL2 1(DE3)。
补充资料：地黄毒
分子式：
CAS号：
性质：又名狄吉妥辛，地吉妥辛，地黄毒，洋地黄毒素。白色或黄白色细微结晶性粉末，无臭，味极苦。熔点256～257℃。旋光度+4.8°(c=1.2，二噁烷)。1g可溶于40ml氯仿、约60ml醇与约400ml乙酸乙酯，也溶于丙酮、戊醇、吡啶，难溶于乙醚、石油醚、水(20°,1g溶于100L水中)。从洋地黄(Digitalis purpurea L.)得到的次生配糖物。以洋地黄叶粉为原料提取浓缩精制而得。其效价约为洋地黄1000倍，能加强心肌收缩力，减慢心率，抑制心脏传导。临床主要用于维持治疗各种原因引起的慢性心功能不全。如II、III度慢性心力衰竭。制剂有片剂，注射剂。
CAS号：
性质：又名狄吉妥辛，地吉妥辛，地黄毒，洋地黄毒素。白色或黄白色细微结晶性粉末，无臭，味极苦。熔点256～257℃。旋光度+4.8°(c=1.2，二噁烷)。1g可溶于40ml氯仿、约60ml醇与约400ml乙酸乙酯，也溶于丙酮、戊醇、吡啶，难溶于乙醚、石油醚、水(20°,1g溶于100L水中)。从洋地黄(Digitalis purpurea L.)得到的次生配糖物。以洋地黄叶粉为原料提取浓缩精制而得。其效价约为洋地黄1000倍，能加强心肌收缩力，减慢心率，抑制心脏传导。临床主要用于维持治疗各种原因引起的慢性心功能不全。如II、III度慢性心力衰竭。制剂有片剂，注射剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条